Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| DE-2022C1-25666 | Other Grant/Funding Number | Patient-Centered Outcomes Research Institute |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hebrew SeniorLife | OTHER |
| MaineHealth | OTHER |
| University of Pennsylvania | OTHER |
| West Penn Allegheny Health System |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following:
Delirium is a common complication of hospitalization and major surgery for older adults, and it can lead to loss of independence and substantial healthcare costs. One approach to preventing delirium is through the Hospital Elder Life Program (HELP). HELP personnel work to prevent delirium by providing orienting communication, assisting patients with walking and exercise, providing help with nutrition and fluids, implementing sleep protocols, and helping patients with vision and hearing aids.
However, it is unknown whether involving family members in these activities along with HELP staff (i.e., "FAM-HELP") might be more effective with preventing delirium. The objective of this clinical trial is thus to compare the traditional HELP program with a family-augmented version of HELP (FAM-HELP) to determine which program is more effective with preventing delirium and related complications in older, hospitalized patients.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hospital Elder Life Program (HELP) | Active Comparator | Hospital Elder Life Program (HELP) is built upon multicomponent, non-pharmacologic strategies that target delirium risk factors to optimize cognitive and clinical function during hospitalization. |
|
| Family-Augmented Hospital Elder Life Program (FAM-HELP) | Active Comparator | The FAM-HELP program will incorporate a family member and/or care partner, who will play a central role with providing bedside support for delirium risk reduction. Family members and care partners will provide social and emotional support along with augmentation of HELP-based protocols. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HELP | Behavioral | This is usual (standard) care across hospitals in this trial. A multidisciplinary team of nurse specialists, social workers, and volunteers implement daily protocols focused on orientation, cognitive stimulation, early mobilization, sleep enhancement, support with visual and hearing aids, mealtime assistance, hydration, reduction in polypharmacy, and nursing-based delirium prevention protocols. |
| Measure | Description | Time Frame |
|---|---|---|
| Delirium Incidence | Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (CAM), supplemented by a validated chart review approach for delirium. | Day of trial enrollment through day of hospital discharge, up to 14 days |
| Delirium Severity | Delirium severity will be scored using the Confusion Assessment Method Long Form Severity Score (CAM-S) (n, 0-19, with higher number indicating more severe delirium). Score derived from the same CAM instrument and items used for delirium incidence. | Day of trial enrollment through day of hospital discharge, up to 14 days |
| Measure | Description | Time Frame |
|---|---|---|
| Delirium Duration | The cumulative number of days (n) with a positive delirium screen will be calculated for all participants | Day of trial enrollment through day of hospital discharge, up to 14 days |
| Persistent Delirium |
| Measure | Description | Time Frame |
|---|---|---|
| Antipsychotic use | Proportion of participants in each group (%) requiring antipsychotic medications during hospitalization | Day of trial enrollment through day of hospital discharge, up to 14 days |
| Restraint use |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eva Schmitt, PhD | Contact | 617-971-5390 | EvaSchmitt@hsl.harvard.edu |
| Name | Affiliation | Role |
|---|---|---|
| Sharon K Inouye, MD | Hebrew SeniorLife | Principal Investigator |
| Phillip E Vlisides, MD | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saddleback Medical Center | Recruiting | Orange | California | 92868 | United States |
Not provided
| OTHER |
| UnityPoint Health - Meriter Hospital | UNKNOWN |
| University of Utah | OTHER |
| MemorialCare Saddleback Medical Center | UNKNOWN |
| Brandeis University | OTHER |
| Indiana University | OTHER |
| Patient-Centered Outcomes Research Institute | OTHER |
Stepped-wedge, cluster randomized
Not provided
Not provided
Not provided
|
| FAM-HELP | Behavioral | Family members and care partners will provide daily emotional and social support during hospitalization. Additionally, family members and care partners will engage in HELP-based protocols throughout the day. The rationale for this protocol augmentation is two-fold: (1) HELP may not consistently have available volunteers (e.g., short-staffing) during a hospital stay, and (2) patients may be more likely to engage in therapeutic activities with a family member given the connection and comfort level. |
|
Positive delirium screen (yes/no) 30 days after hospital discharge as determined by the long-form Confusion Assessment Method (AM)
| 30 days after hospital discharge |
| Delirium Burden - Patient | Delirium burden will be calculated using the Patient Delirium Burden Scale (DEL-B-P) (n, 0-40, with higher number indicating more severe burden) | Day of trial enrollment through 30 days after discharge |
| Delirium Burden - Family and Care Partners | Delirium burden will be calculated using the Patient Delirium Family Caregiver Scale (DEL-B-C) (n, 0-40, with higher number indicating more severe burden) | Day of trial enrollment through 30 days after discharge |
| Caregiving Strain | Strain associated with patient caregiving will be assessed via Modified Caregiver Strain Index (MCSI) (n, 0-26, with higher number indicating more caregiver strain) | Hospital discharge through 30 days after discharge |
| Cognitive Function - Subjective Reporting | Subjective reporting of cognitive function will be assessed via PROMIS Cognitive Function - Short Form 6a (n, 6-30, with higher number indicating better subjective cognitive function) | Hospital discharge through 30 days after discharge |
| Hospital Experience | Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey (n, 7-28, with higher score indicating better hospital experience) | Day of hospital discharge (typically up to 30 days after hospital admission, may extend to 60 or more days) |
| Global Health | Assessment of overall physical and mental health via PROMIS Global Health-10. Two separate subscales will be calculated, Global Physical Health (n, 4-20) and Global Mental Health (n, 4-20), with higher scores indicating better health. | Hospital discharge through 30 days after discharge |
| Physical Function | Assessment of physical function via PROMIS Physical Short Form 10a (n, 10-50, with higher scores indicating better physical function). | 30 days after hospital discharge |
| Falls | Proportion of participants in each group (%) experiencing at least one fall | Day of trial enrollment through 30 days after hospital discharge |
| Length of Hospital Stay | Total number of days (n) spent in the hospital | Day of hospital admission through hospital discharge (typically up to 30 days after hospital admission, may extend to 60 or more days) |
| Discharge Disposition | Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility) | Day of hospital discharge through 30 days after discharge |
| 30-Day Readmission | Proportion of participants in each group (%) requiring hospital readmission | Day of hospital discharge through 30 days after discharge |
Proportion of participants in each group (%) requiring restraint use during hospitalization
| Day of trial enrollment through day of hospital discharge, up to 14 days |
| Mortality | Incidence (%) | Day of trial enrollment through 30 days after discharge |
| MaineHealth | Recruiting | Portland | Maine | 04102 | United States |
|
| Michigan Medicine | Recruiting | Ann Arbor | Michigan | 48109 | United States |
|
| Hospital of the University of Pennsylvania | Recruiting | Philadelphia | Pennsylvania | 19104 | United States |
|
| Allegheny General Hospital | Recruiting | Pittsburgh | Pennsylvania | 15212 | United States |
|
| University of Utah | Recruiting | Salt Lake City | Utah | 84132 | United States |
|
| Meriter Hospital | Recruiting | Madison | Wisconsin | 53715 | United States |
|
| ID | Term |
|---|---|
| D003693 | Delirium |
| D019965 | Neurocognitive Disorders |
| D060825 | Cognitive Dysfunction |
| D000544 | Alzheimer Disease |
| D000084802 | Caregiver Burden |
| D017060 | Patient Satisfaction |
| ID | Term |
|---|---|
| D003221 | Confusion |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001523 | Mental Disorders |
| D003072 | Cognition Disorders |
| D003704 | Dementia |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D024801 | Tauopathies |
| D019636 | Neurodegenerative Diseases |
| D013315 | Stress, Psychological |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
Not provided
Not provided